...
首页> 外文期刊>Journal of laparoendoscopic and advanced surgical techniques, Part A >Total and Subtotal Laparoscopic Gastrectomy for the Treatment of Advanced Gastric Cancer: Morbidity and Oncological Outcomes
【24h】

Total and Subtotal Laparoscopic Gastrectomy for the Treatment of Advanced Gastric Cancer: Morbidity and Oncological Outcomes

机译:腹腔镜胃切除术治疗晚期胃癌:发病率和肿瘤学结果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: A debate is still surrounding the use of laparoscopic surgery for advanced gastric cancer (AGC) related to doubts about the requirements to satisfy oncologic criteria. The aim of this study is to analyze the oncological results, the intraoperative complications, and the short- and medium-term morbidity and mortality in patients with AGC who underwent subtotal laparoscopic gastrectomy (SLG) or total laparoscopic gastrectomy (TLG) with extended lymphadenectomy. Materials and Methods: We reviewed medical records of patients who underwent radical gastrectomy for AGC started laparoscopically with the intent of curative surgery, between July 2007 and October 2015. We recruited 74 patients and studied demographics, American Society of Anesthesiologists (ASA) score, pTNM stage, histologic pattern of the tumor, duration of surgery, conversion rate, estimated blood loss, number of resected lymph nodes, type of gastrointestinal reconstruction, postoperative complication, mortality rate, length of stay, time to canalization and resumption of food intake, and overall and disease-free survival rate. Results: We performed 74 interventions, with a conversion rate of 14.9% (11/74). Sixty-three were performed totally as laparoscopic: 43 (68.25%) SLGs and 20 (31.75%) TLGs, all with an extended lymphadenectomy (D2 or more). Operative time was 150 ± 34 minutes (range 75–225 minutes), the mean number of resected lymph nodes 21.4 ± 6.2, global morbidity rate 25.39%, rate of reoperation 9.52%, and perioperative mortality at 30 days 0%. We performed an average follow-up of 48.7 months (range 18–60), and we observed 5-year overall and disease-free survival, respectively, of 48.6% and 42.7%. Conclusions: LG with extended lymphadenectomy for AGC is a feasible procedure with good results in terms of postoperative course, complications, and mortality. Thanks to the use of extremely precise and safe technologies the extended lymphadenectomy can be performed laparoscopically. The laparoscopic approach, when performed by experienced surgeons, ensures a correct oncological treatment in combination with the benefits of the laparoscopic technique.
机译:背景:辩论仍在围绕腹腔镜手术对晚期胃癌(AGC)的用途,与满足肿瘤标准的要求怀疑。本研究的目的是分析肿瘤学结果,术中并发症以及AGC患者的短期和中期发病率和死亡率,患有延长淋巴结切除术的椎间膜腹腔镜胃切除术(SLG)或总腹腔镜胃切除术(TLG)。材料和方法:我们审查了在2007年7月至2015年7月至10月期间仔细腹腔镜腹腔镜进行激进胃切除术的患者的病程。我们招募了74名患者,研究了美国麻醉师学会(ASA)评分,研究人口统计学,PTNM阶段,组织学模式的肿瘤,手术持续时间,转化率,估计失血,切除淋巴结的数量,胃肠道重建的类型,术后并发症,死亡率,停留时间长,可调用和恢复食物摄入的时间,以及恢复食物摄入量,和食物摄入的时间总体和无病生存率。结果:我们进行了74次干预措施,转换率为14.9%(11/74)。六十三个完全如腹腔镜:43(68.25%)SLG和20(31.75%)TLG,全部有延长的淋巴结切除术(D2或更多)。手术时间为150±34分钟(范围75-225分钟),切除淋巴结的平均数量21.4±6.2,全球发病率为25.39%,再跑期率为9.52%,周围死亡率为30天0%。我们的平均随访48.7个月(范围为18-60),我们分别观察到5年的总体和无病生存率,48.6%和42.7%。结论:随着AGC扩展淋巴结切除术的LG是一种可行的程序,术后术语,并发症和死亡率良好。由于使用极其精确和安全的技术,可以在腹腔镜上进行延长的淋巴结切除术。当由经验丰富的外科医生进行时,腹腔镜方法确保了与腹腔镜技术的益处相结合的正确肿瘤治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号